Skip to main content

Table 1 Clinical variables

From: Systemic vascular function, measured with forearm flow mediated dilatation, in acute and stable cerebrovascular disease: a case-control study

 

Recent Stroke/TIA n = 17

Stable Disease n = 17

p

Gender, n = F

6 (35%)

6 (35%)

 

Age at FMD scan, years

64.2 ± 13.0

64.7 ± 11.7

0.23

Medical History

   

Myocardial Infarction

2 (12%)

1 (6%)

1.0

Hypertension

15 (89%)

15 (89%)

1.0

Hypercholesterolaemia

11 (65%)

12 (71%)

0.71

Diabetes

2 (12%)

3 (18%)

1.0

Smoking

9 (53%)

9 (53%)

1.0

Prior Therapy

   

Antihypertensive

12 (71%)

14 (83%)

0.6

Lipid Lowering

12 (71%)

11 (65%)

0.72

Clinical Variables

   

Clinical Syndrome TACS

1 (6%)

2 (12%)

 

PACS

6 (35%)

4 (24%)

 

LACS

4 (24%)

6 (35%)

 

POCS

2 (12%)

1 (6%)

 

TIA

4 (24%)

4 (24%)

 

SBP, mmHg

139.9 ± 21.0

138.9 ± 18.7

0.86

DBP, mm Hg

84.1 ± 13.6

79.6 ± 14.7

0.21

Cholesterol, mmolL-1

3.9 ± 0.9

4.2 ± 0.9

0.44

Triglycerides,

1.1 ± 0.3

1.3 ± 0.5

0.25

HDL, mmolL-1

2.1 ± 1.1

2.2 ± 0.6

0.77

LDL, mmolL-1

1.3 ± 0.5

1.4 ± 0.6

0.52

  1. Data are N (%) or N ± SD; TACI = Total Anterior Circulation, PACI = Partial Anterior Circulation, LACI = Lacunar, TIA = Transient Ischaemic attack; S(D)BP = Systolic (Diastolic) Blood Pressure; H(L)DL = High (Low) Density Lipoprotein